Patients With Advanced Solid Tumors Clinical Trial
Official title:
A Phase 1, Multi-Center, Open-Label Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT7104 in Patients With Advanced Solid Tumours
This is a prospective multi-centre, Open-Label Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT7104 in Patients with Advanced Solid Tumours in Australia.
n/a
NCT number | NCT05200013 |
Study type | Interventional |
Source | Bio-Thera Solutions |
Contact | Lesley Liu |
Phone | +86-20-32203220 |
[email protected] | |
Status | Recruiting |
Phase | Phase 1 |
Start date | April 29, 2022 |
Completion date | December 31, 2024 |